KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Gains from Sales and Divestitures (2016 - 2019)

Exact Sciences has reported Gains from Sales and Divestitures over the past 10 years, most recently at $3.5 million for Q2 2019.

  • Quarterly Gains from Sales and Divestitures rose 271.43% to $3.5 million in Q2 2019 from the year-ago period, while the trailing twelve-month figure was $3.5 million through Jun 2019, up 271.43% year-over-year, with the annual reading at $1.3 million for FY2018, 12.85% up from the prior year.
  • Gains from Sales and Divestitures was $3.5 million for Q2 2019 at Exact Sciences, up from $3.4 million in the prior quarter.
  • Over five years, Gains from Sales and Divestitures peaked at $3.5 million in Q2 2019 and troughed at $237061.0 in Q1 2015.
  • The 5-year median for Gains from Sales and Divestitures is $817710.0 (2016), against an average of $1.1 million.
  • Year-over-year, Gains from Sales and Divestitures increased 11.84% in 2018 and then surged 286.5% in 2019.
  • A 5-year view of Gains from Sales and Divestitures shows it stood at $578033.0 in 2015, then soared by 37.74% to $796168.0 in 2016, then surged by 42.21% to $1.1 million in 2017, then rose by 12.85% to $1.3 million in 2018, then surged by 174.4% to $3.5 million in 2019.
  • Per Business Quant, the three most recent readings for EXAS's Gains from Sales and Divestitures are $3.5 million (Q2 2019), $3.4 million (Q1 2019), and $1.3 million (Q4 2018).